In vivo effects of pancreozymin, secretin, vasoactive intestinal polypeptide and pilocarpine on the levels of cyclic AMP and cyclic GMP in the rat pancreas.
D000681:Amylases / Q000378:metabolism; D000818:Animals; D001652:Bile Ducts; D002404:Catheterization; D002766:Cholecystokinin / Q000502:physiology*; D002852:Chromatography, Ion Exchange; D000242:Cyclic AMP / Q000378:metabolism*; D006152:Cyclic GMP / Q000378:metabolism*; D005768:Gastrointestinal Hormones / Q000494:pharmacology*; D007422:Intestines; D008297:Male; D010179:Pancreas / Q000187:drug effects / Q000201:enzymology / Q000378:metabolism* / Q000502:physiology; D010455:Peptides / Q000494:pharmacology*; D010862:Pilocarpine / Q000494:pharmacology*; D011863:Radioimmunoassay; D011869:Radioligand Assay; D051381:Rats; D012633:Secretin / Q000502:physiology*; D013217:Starvation; D013997:Time Factors
D005768:Gastrointestinal Hormones; D010455:Peptides; D010862:Pilocarpine; D012633:Secretin; D002766:Cholecystokinin; D000242:Cyclic AMP; D000681:Amylases; D006152:Cyclic GMP